MedPath

ORAL PLAN ANTIBACTERIAL MOUTHRINSE WITH FLUORIDE

ORAL PLAN ANTIBACTERIAL MOUTHRINSE WITH FLUORIDE

Discontinued
DIN Number

02209160

Drug Class

Human

Market Date

May 28, 1999

Company
HC

ABBOTT LABORATORIES, LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02209160
AIG Number0328439001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A01AA51 SODIUM FLUORIDE, COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationDental
AHFS Classification52:28.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

CETYLPYRIDINIUM CHLORIDEActive
Strength: .025 %
Monograph: CETYLPYRIDINIUM CHLORIDE
SODIUM FLUORIDEActive
Strength: .025 %
Monograph: SODIUM FLUORIDE
TRICLOSANActive
Strength: .03 %
Monograph: TRICLOSAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.